{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:34:44Z","timestamp":1762508084236},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,7,1]]},"DOI":"10.2169\/internalmedicine.4505-20","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T22:04:07Z","timestamp":1586383447000},"page":"1655-1658","source":"Crossref","is-referenced-by-count":4,"title":["The First Case Report of Acute Symptomatic HEV Genotype 4 Infection in an HIV-positive Patient in Japan"],"prefix":"10.2169","volume":"59","author":[{"given":"Satoshi","family":"Kitaura","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"},{"name":"Department of Internal Medicine, Teikyo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahoko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Okugawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital, Japan"},{"name":"Department of Infection Control and Prevention, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 68: 818-824, 1980.","DOI":"10.1016\/0002-9343(80)90200-4"},{"key":"2","unstructured":"2. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390: 1151-1210, 2017."},{"key":"3","unstructured":"3. Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther 46: 126-141, 2017."},{"key":"4","unstructured":"4. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 6: 5-36, 2006."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res 44: 43-58, 2014.","DOI":"10.1111\/hepr.12175"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rivero-Juarez A, Lopez-Lopez P, Frias M, Rivero A. Hepatitis E infection in HIV-infected patients. Front Microbiol 10: 1425, 2019.","DOI":"10.3389\/fmicb.2019.01425"},{"key":"7","unstructured":"7. Rivero-Juarez A, Cuenca-Lopez F, Martinez-Peinado A, et al. Rural habitat as risk factor for hepatitis E virus seroconversion in HIV-infected patients: a prospective longitudinal study. Zoonoses Public Health 64: e60-e4, 2017."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pineda JA, Cifuentes C, Parra M, et al. Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. Aids 28: 1931-1937, 2014.","DOI":"10.1097\/QAD.0000000000000378"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zeng H, Wang L, Liu P, Liao L, Wang L, Shao Y. Seroprevalence of hepatitis E virus in HIV-infected patients in China. Aids 31: 2019-2021, 2017.","DOI":"10.1097\/QAD.0000000000001585"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Debes JD, Pisano MB, Lotto M, Re V. Hepatitis E virus infection in the HIV-positive patient. J Clin Virol 80: 102-106, 2016.","DOI":"10.1016\/j.jcv.2016.05.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shrestha A, Adhikari A, Bhattarai M, et al. Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal. Virol J 14: 228, 2017.","DOI":"10.1186\/s12985-017-0899-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kenfak-Foguena A, Sch\u00f6ni-Affolter F, B\u00fcrgisser P, et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 17: 1074-1078, 2011.","DOI":"10.3201\/eid\/1706.101067"},{"key":"13","unstructured":"13. Goel A, Aggarwal R. Advances in hepatitis E - II: epidemiology, clinical manifestations, treatment and prevention. Expert Rev Gastroenterol Hepatol 10: 1065-1074, 2016."},{"key":"14","unstructured":"14. Aggarwal R, Goel A. Advances in hepatitis E - I: virology, pathogenesis and diagnosis. Expert Rev Gastroenterol Hepatol 10: 1053-1063, 2016."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Geng Y, Zhang H, Huang W, et al. Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon 14: e15618, 2014.","DOI":"10.5812\/hepatmon.15618"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakano T, Takahashi K, Takahashi M, et al. Investigating the origin and global dispersal history of hepatitis E virus genotype 4 using phylogeographical analysis. Liver Int 36: 31-41, 2016.","DOI":"10.1111\/liv.12880"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takahashi M, Tamura K, Hoshino Y, et al. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol 82: 271-281, 2010.","DOI":"10.1002\/jmv.21678"},{"key":"18","unstructured":"18. Yazaki Y, Sugawara K, Honda M, et al. Characteristics of 20 patients with autochthonous acute hepatitis E in Hokkaido, Japan: first report of bilateral facial palsy following the infection with genotype 4 hepatitis E virus. Tohoku J Exp Med 236: 263-271, 2015."},{"key":"19","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1111\/j.1537-2995.2008.01910.x","volume":"48","author":"H Sakata","year":"2008","unstructured":"19. Sakata H, Matsubayashi K, Takeda H, et al. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 48: 2568-2576, 2008.","journal-title":"Transfusion","ISSN":"http:\/\/id.crossref.org\/issn\/0041-1132","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ohnishi S, Kang JH, Maekubo H, et al. Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan. Hepatol Res 36: 301-307, 2006.","DOI":"10.1016\/j.hepres.2006.08.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 76: 341-349, 2005.","DOI":"10.1002\/jmv.20364"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lin KY, Lin PH, Sun HY, et al. Hepatitis E virus infections among HIV-positive individuals during an outbreak of acute hepatitis A in Taiwan. Hepatology 70: 1892-1902, 2019.","DOI":"10.1002\/hep.30771"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hakze-van der Honing RW, van Coillie E, Antonis AF, van der Poel WH. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 6: e22673, 2011.","DOI":"10.1371\/journal.pone.0022673"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Colson P, Romanet P, Moal V, et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 18: 1361-1364, 2012.","DOI":"10.3201\/eid1808.111827"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Bouamra Y, Gerolami R, Arzouni JP, et al. Emergence of autochthonous infections with hepatitis E virus of genotype 4 in Europe. Intervirology 57: 43-48, 2014.","DOI":"10.1159\/000354801"},{"key":"26","unstructured":"26. Tesse S, Lioure B, Fornecker L, et al. Circulation of genotype 4 hepatitis E virus in Europe: first autochthonous hepatitis E infection in France. J Clin Virol 54: 197-200, 2012."},{"key":"27","unstructured":"27. Jeblaoui A, Haim-Boukobza S, Marchadier E, Mokhtari C, Roque-Afonso AM. Genotype 4 hepatitis e virus in france: an autochthonous infection with a more severe presentation. Clin Infect Dis 57: e122-e126, 2013."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bharti AR, Letendre SL, Wolfson T, et al. Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol 52: 328-332, 2011.","DOI":"10.1016\/j.jcv.2011.08.021"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chamie G, Bonacini M, Bangsberg DR, et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 44: 577-583, 2007.","DOI":"10.1086\/511038"},{"key":"30","unstructured":"30. Aggarwal R, Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 15: 9-20, 2000."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/13\/59_4505-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T03:31:42Z","timestamp":1593833502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/13\/59_4505-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4505-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}